Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEBIVOLOL Cause Therapy non-responder? 37 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Therapy non-responder have been filed in association with NEBIVOLOL (nebivolol). This represents 0.6% of all adverse event reports for NEBIVOLOL.

37
Reports of Therapy non-responder with NEBIVOLOL
0.6%
of all NEBIVOLOL reports
0
Deaths
15
Hospitalizations

How Dangerous Is Therapy non-responder From NEBIVOLOL?

Of the 37 reports, 15 (40.5%) required hospitalization.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does NEBIVOLOL Cause?

Hypotension (487) Drug ineffective (430) Bradycardia (371) Dyspnoea (364) Fall (320) Acute kidney injury (300) Dizziness (294) Off label use (277) Fatigue (257) Hypertension (249)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which NEBIVOLOL Alternatives Have Lower Therapy non-responder Risk?

NEBIVOLOL vs NECITUMUMAB NEBIVOLOL vs NEDAPLATIN NEBIVOLOL vs NEFAZODONE NEBIVOLOL vs NEFOPAM NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG

Related Pages

NEBIVOLOL Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder NEBIVOLOL Demographics